Committees

Brexit and the implications for UK business: Pharmaceuticals inquiry

Inquiry

This is the pharmaceuticals strand of the Committee's Brexit and the implications for UK business inquiry.

The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, R&D, trade opportunities and transitional arrangements.

Upcoming events

View all events

No upcoming events scheduled

Past events

Tuesday 5 December 2017
9:45am Public
Brexit and the implications for UK business: Pharmaceuticals inquiry - Oral evidence 5 December 2017
Room 5, Palace of Westminster

Contact us

We receive a significant number of emails each day. All requests and invitations are considered but we do not respond directly to everyone. Please be aware, the committee does not look at individual cases or specific complaints.